Fetal growth
US5858966A · kind A · utility
1Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 10, 1997 |
| Grant date | Jan 12, 1999 |
| Priority date | — |
| Expiry date | Jun 10, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of enhancing fetal growth and/or development and/or neonatal survival by the administration over a period of insulin-like growth factor (IGF-1), to either the amniotic fluid or direct to the fetal gastrointestinal tract. Administration may be by way of an ultrasonically monitored injection or placement of a catheter.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.